News Room

21

Oct 21

Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction,...
Read More

13

Oct 21

Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer

Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer Agilent Technologies Inc. (NYSE:...
Read More

29

Sep 21

GE Healthcare Debuts MyoSPECT, A Next-Generation Nuclear Medicine Cardiology System That Gets to the Heart of Challenging Cardiovascular Cases

GE Healthcare Debuts MyoSPECT, A Next-Generation Nuclear Medicine Cardiology System That Gets to the Heart of Challenging Cardiovascular Cases GE...
Read More

17

Sep 21

Start of the Magnetic Resonance Outcome (MRO) study to evaluate the ClearCoast™ MRI system

Start of the Magnetic Resonance Outcome (MRO) study to evaluate the ClearCoast™ MRI system The ClearCoast™ MRI system makes it...
Read More

17

Sep 21

New name: ClearSight™ has become ClearCoast™

New name: ClearSight™ has become ClearCoast™ ClearCut Medical Ltd. has changed the name of its diffusion-weighted MRI technology for intraoperative...
Read More

16

Sep 21

A Deep-Learning Model May Help Predict Lung Cancer Survival and Outcomes

A Deep-Learning Model May Help Predict Lung Cancer Survival and Outcomes A deep-learning model developed using serial image scans of...
Read More

2

Sep 21

Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement

Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement Agilent Technologies Inc. (NYSE: A) today announced the signing of a...
Read More

23

Aug 21

Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer

Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer PD-L1 IHC 22C3 pharmDx can now be used...
Read More

10

Aug 21

ESP Virtual Congress 2021

ESP Virtual Congress 2021 Milestone will participate to the 33nd European Congress of Pathology, from 29th to 31st August 2021,...
Read More

27

Jul 21

Clinical Utility of ALK Fusion Detection by Liquid Biopsy

Clinical Utility of ALK Fusion Detection by Liquid Biopsy Cell-free DNA NGS detects common and novel ALK fusions in the...
Read More
1 2 3 5